Mustang Bio to Participate in Two August 2023 Investor Conferences

<p>WORCESTER, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced that Manuel Litchman, M.D., President and Chief Executive Officer, will participate in two investor […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/mustang-bio-to-participate-in-two-august-2023-investor-conferences/">Mustang Bio to Participate in Two August 2023 Investor Conferences</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>